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Abstract
Metastatic pheochromocytoma in the spine is rare, and there is no standard curative management. Treatment via open surgery is
often risky in the perioperative period, while osteoplasty by cement augmentation is a less invasive option.
We describe 2 patients with recurrence of pheochromocytoma involving the spine and the pelvis who were successfully treated
with osteoplasty by cement augmentation. A 31-year-old female underwent cement augmentation for a pelvic lesion 6 months after
the resection and screw ﬁxation of an L3 lesion. A 58-year-old male underwent cement augmentation to directly destroy the
functional tumor, with a surgical decompression 6 months later. Both patients showed appropriate destruction of the tumor,
adequate pain relief, and the decreased release of catecholamine from metastatic lesions.
Osteoplasty by cement augmentation may be a treatment option for patients with metastatic pheochromocytoma who cannot
undergo appropriate surgery or decline surgery. This represents a safe approach to sustainably relieve pain and stabilize vertebral
bodies with metastatic malignant pheochromocytoma.
Abbreviations: BP = blood pressure, cGy = centigray, ECG = electrocardiograph, UCG = ultrasonic cardiogram.
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1. Introduction
Pheochromocytomas are rare tumors with an incidence of 1 per
100,000 per year, 10% to 20% of which will develop to
malignant extraadrenal pheochromocytoma.[1] Malignancy is
deﬁned by the presence of metastases and local invasion rather
than by histological criteria. Spinal metastases are extremely rare,
with various clinical presentations based on the primary lytic
bone lesions that cause destruction or compression of the spinal
cord, clinically manifesting as pain or neurological deﬁcit.[1,2]
Previous reports investigating treatment methods for malignant
tumor in the spine have studied preoperative embolization of
vascular supply, chemotherapy and/or radiotherapy, and/or
tumor resection,[3] and concluded that open curative resection of
the sectional lesion was effective. However, open surgery carries
marked challenges including hemodynamic drastic ﬂuctuation
induced by catecholamine secretion from the tumor, blood loss
caused by lesion destruction, and spinal stabilization.[4] Herein,
we present 2 cases in which pheochromocytoma of the spine was
successfully treated via osteoplasty by cement augmentation for
the ﬁrst time; this method deactivated the neuroendocrine
systems, reduced perioperative blood loss, and stabilized the
spine. Written informed consent was obtained from the patient
for publication of this article. A copy of the written consent is
available for review by the editors of MEDICINE. Because this
article does not involve any human or animal trials, there is no
need to conduct special ethic review and the ethical approval is
not necessary.
2. Case reports
2.1. Case 1
2.1.1. History and examination. A 31-year-old female with a
17-year history of hypertension (maximum blood pressure (BP)
200/120mm Hg) underwent surgical resection of adrenal
pheochromocytoma 5 years previously. Postoperative BP
returned to normal with no evidence of distant metastasis during
a 4-year follow-up. However, the patient experienced severe
paroxysmal headaches provoked by hypertensive peaks, moder-
ate low back pain and numbness of the right lower limb for 1 year
before being referred to our hospital.
Two extraadrenal pheochromocytomas were found, with no
recurrence of the primary tumor (Fig. 1A). The lesions were
protruding into the spinal canal and causing lumbar canal
stenosis. Preoperative assessment was performed, including
routine laboratory tests (electrolytes, kidney function tests,
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complete blood count), cardiac function (electrocardiograph
(ECG), ultrasonic cardiogram (UCG), chest radiography), and
endocrinological evaluation (plasma chromogranin A, meta-
nephrines, catecholamines). Urine catecholamine was 133.71mg/
24hour (normal: <50mg/24hour).
We initially planned a 2-step resection of the L3 and pelvic
lesions. The patient was medically optimized with alpha- and
beta-adrenergic blockers for 6 weeks, and showed reduced
catecholamine and normal BP.
2.1.2. The ﬁrst operation. The patient was placed in the prone
position under general anesthesia. We exposed the L2-L5 spinous
processes and laminae, resected a 3cm3cm2cm dark purple
tumor mass on the right facet between L3/4 and the L3 pedicle,
and performed ﬁxation using a Moss SI screw-rod system.
Perioperative BP was stable and intraoperative blood loss was
800mL. Pathological examination was positive for chromogra-
nin A, synaptophysin and P53, occasionally positive for S-100,
but negative for melan-A and calretinin, which conﬁrmed the
diagnosis of pheochromocytoma (Fig. 1B).
The patient refused radiotherapy and was discharged after 8
days with ongoing beta-blocker medication. One month later, the
urine catecholamine had reduced to 39.09mg/24hour and BPwas
normal. However, BP rose (up to 150/100mmHg) after cessation
of antihypertensive drugs, and urine catecholamine increased to
139.50mg/24hour 3 months after surgery. The BP remained high
(140/90mm Hg) at the next 2-month follow-up, despite ongoing
beta-blocker administration.
2.1.3. The second operation. Six months later, the patient was
too scared to undergo the previously designed resection of the
pelvic lesion. The patient instead gave permission for percutane-
ous osteoplasty by polymethylmethacrylate to be performed
under local anesthesia (Fig. 1C). The BP markedly increased to
200/120mm Hg when the needle penetrated the tumor, but had
decreased to normal after 2minutes. The patient was discharged
2 days later without complication.
2.1.4. Follow-up. The beta-blocker medication was gradually
reduced and was stopped at 2 months postoperatively. During 2
years of follow-up, both BP and urine catecholamine were
normal. There were no complications associated with osteoplasty
during the follow-up period.
2.2. Case 2
2.2.1. History and examination. A 58-year-old male underwent
complete excision of right retroperitoneal pheochromocytoma
with no metastasis 4 years previously. The patient experienced
high BP (range 160–120/135–90mm Hg) and progressive low
back pain with radiating pain to the right lower limb for 1 year.
Physical examination revealed a stiff lumbar region, right lower
limb hyperesthesia, positive Lasegue’s sign, and urine catechol-
amine of up to 151.24mg/24hour. Computed tomography and
plain radiography revealed a soft mass outside the sacrum, as well
as a compressed dural sac, which was conﬁrmed by bone
scanning (Fig. 2A and B). The patient was medically optimized
with phenoxybenzamine and an alpha-adrenergic blocker.
2.2.2. The ﬁrst operation. Cement augmentation was per-
formed to destroy the functional tumor with temporary
embolization of the internal iliac artery under local anesthesia
(Fig. 2C). The BP and heart rate markedly increased to 220/150
Figure 1. Case 1. (A) MRI showing enhanced lesions in the right pedicle and facet of L3 and the right ilium. (B) Hematoxylin and eosin-stained histological sections
from the biopsy specimen conﬁrmed extraadrenal pheochromocytoma. (C) The location of 2-step surgery. In the ﬁrst operation, paraganglioma in L3 was resected
and reconstructed with a screw and rod system; 6 months later, osteoplasty procedure by cement was done in the right posterior ilium.
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mm Hg and 140beats/minute, respectively, when the needle
penetrated the tumor, and gradually decreased to normal within
5minutes. Pathological examination conﬁrmed the diagnosis of
pheochromocytoma (Fig. 2D). Postoperatively, the patient
experienced pain relief with no improvement of leg numbness.
The patient was unwilling to undergo further treatment and was
discharged after 8 days.
2.2.3. The second operation. The dosage of phenoxybenz-
amine was gradually reduced. The BP remained normal, and
phenoxybenzamine was stopped 2 months later. Six months
later, surgical decompression was performed to improve the
impairment caused by the cement (Fig. 2E), with intraoperative
blood loss of 400mL. Nerve impairment improved to almost
normal.
2.2.4. Follow-up. To date, the patient has no recurrent
symptoms in 6 months of follow-up. The latest urine catechol-
amine was 21.43mg/24hour. There were no complications
associated with osteoplasty during the follow-up period.
3. Discussion
Reports of spinal pheochromocytoma are rare, 35% of which are
metastases.[2] Low back pain and sciatica are common presenta-
tions, with progressive hyperesthesia and sensory-motor dysfunc-
tion[5]; elevated BP and headache due to catecholamines are less
common.[1] All of these symptoms were present in the cases in the
present report. Most previous cases with metastatic pheochro-
mocytoma have undergone preoperative embolization, chemo-
therapy and/or radiotherapy, and/or tumor resection.[3] Inspired
by percutaneous ethanol and cryoablation treatment of tumor-
induced osteomalacia,[6] we attempted cement augmentation here
for the ﬁrst time.Metastatic pheochromocytoma is hypervascular
and therefore carries a high risk of perioperative blood loss,
generally requiring preoperative embolization.[5] We minimized
this risk of blood loss with a new strategy of managing
intraoperative bleeding by using cement only or performing
perioperative temporary embolization.Our resultswere similar to
previous reports, in that the cement could provide adequate
stability to maintain the column solidity and relieve pain.[7] We
further conﬁrmed tumor destruction immediately after surgery,
due to the reduction in catecholamine levels and change in related
symptoms caused by cell toxicity andhyperthermic cytotoxicity of
cement. Although alpha- and beta-blockers were used for
preoperative adjustment, perioperative BP still increased rapidly
when the needle penetrated the tumor. This increasing BP
progressively decreased back to normal levels in less than 5
minutes. Continual monitoring and vasoactive preparation were
needed, although blood loss was small. One postoperative
complication was cement leakage into the canal and subsequent
spinal cord compression. There was no sign of tumor recurrence
during follow-up (2.5 and 1 year, respectively) in the
present study, indicating that the local malignant tumors were
eradicated.
Figure 2. Case 2. (A) Computed tomography showing the lesion in the sacrum. (B) 99mTc HYNIC TOC SPECT/CT scans showing uptake in the same area. (C) The
back wall of the S1 vertebral body was deﬁcient and the cement leaked into the canal. (D) Hematoxylin and eosin-stained histological sections from the biopsy
specimen conﬁrmed extraadrenal pheochromocytoma. (E) Decompression operation was undertaken 2 months after the sacroplasty procedure.
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Only 4 sacral pheochromocytomas have been reported since
1998. Coles et al[8] enucleated the S3 tumor posteriorly, and the
patient was disease-free after 2 years of follow-up. Another case
with a tumor at S1 underwent therapy with I131 metaiodoben-
zylguanidine continually after failure of radiotherapy, and
showed no tumor growth after 5 years.[9] A third case with an
S1–S2 lesion underwent open resection and received a total dose
of 3000cGy in 10 fractions,[10] with no follow-up. In the fourth
case, the sacral tumor was effectively treated with a combination
of 4 methods, including preoperative sacral embolization,
percutaneous cryoablation, alcohol ablation, and sacro-
plasty.[11]. In the present report, we conﬁrmed that osteoplasty
was able to relieve local pain caused by metastatic spinal
pheochromocytoma in 2 cases.
To date, surgical management of spinal pheochromocytoma
has remained under evaluation, with no standard criteria. We
described the ﬁrst 2 cases of metastatic spinal pheochromocyto-
ma that underwent cement augmentation. In both cases, the local
tumor was successfully controlled, with pain relief and decreased
catecholamine levels. This might be a useful strategy to achieve
rapid and sustained neurological improvements for patients with
recurrence of pheochromocytoma involving the spine and the
pelvis. Although there were no complications associated with
osteoplasty in these 2 patients, the safety of this approach still
needs to be conﬁrmed in studies with larger sample sizes and
longer follow-up periods. Surgical time, cement volume, and
velocity are critical factors that need further investigation.
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